Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Or the bong...
Not neccessarily. Tesla vs Edison. Tag molecule - then detected how? Lots of holes in the info they have put out there.
If the logic of first to market was true we'd only have one auto manufacturer. There is plenty of room in this market, I'm hoping Cannabix is first, there is still plenty of room for Hound and anyone else who decides to jump in.
The potential market is huge - between law enforcement, private companies using these technologies to enforce substance abuse policies, etc. With our friends at Hound Labs being so secretive as to how they are achieving their measurements I am personally sceptical as to how their device works. With the Cannabix model and the information they have put out I have a lot of confidence in the UF analytical chemistry department and what they bring to the table. My opinion is that Cannabix Technologies is a legitimate contender, Hound Labs may or may not be. It seems that Cannabix is moving forward, albeit at glacial speed at times, and will have a marketable unit in time. Without more info on Hound Labs I can't even speculate on where they are, if their unit should work as stated, etc. With recent articles stating that spit and urine are unreliable on determining blood concentration I am much less worried about those competitors. So, my conclusion is that Cannabix has been more open as to how their device works, and may be either first or second to market with a workable unit. The market is big enough for a handful of units from different manufacturers, I'm still holding long.
The company establishing its own analytical lab also seems to point in the direction that the development work with UF is pretty much done, which mirrors the comments on the grant expiring at the end of last year. If indeed they are pushing to complete testing by the close of the month, that is great news. Licenses in place, patent rights obtained, testing underway, personnel retained to complete development and testing, personnel in place to help gain acceptance in the law enforcement community - things appear to be headed in a very positive direction.
Let's hope I'm right - the lack of concrete statements is unnerving. I have a lot of faith in UF and the value they put on their "brand". That is what has kept me in over the past two years. If this was three guys in a garage in British Columbia giving the same updates I'd have been gone a long time ago. As of the close of February all of my holdings are long term, I'm looking at this as significant contribution to my retirement. If it hits, things will go nicely. If not, I'm still in good shape but I'll be working awhile longer.
The "deal" with UF was a research grant to develop the breathalyzer which ran a specified term. That has concluded. If more development effort is needed it would be reasonable to assume that another grant would be needed to fund it. That is separate from the licensing agreement of the patent rights. Cannabix Technologies still has rights to the patent and can use the technology covered by the patent to continue to develop, test and market a device.
These are my words, my interpretation. Take them for what you will.
Agreed – anyone telling folks to sell or buy, beware. Everything is an opinion. Look for statements of fact and then research them and form your own opinion / strategy. What I am looking for is some statement from the company telling me clearly that (1) the device is complete to a stage that is able to be fielded for testing, and (2) what tests are planned (or ongoing). Beyond that, I personally cannot see the need to FDA test it (it does not go in a person’s body, and is not used for medical diagnosis). I see the need to persuade the courts to accept the results of the breathalyzer analysis of human breath for the presence of THC. I think it will be up to the courts to determine if the acceptable level of unmetabolized THC in human blood / breath while operating a motor vehicle is zero, .05, .5, 5, 50, or 500. Cannabix has staff that are there to influence the court acceptance of results, and help the court determine a conviction criteria / level. I am personally in long, have been for almost two years. I have a lot of faith in the UF faculty, in aggregate they have a very good record of success (think Gatorade). From my observation they don’t put the University’s name at risk over something that might not work. Like any university, they are very dependent on grants, and the grantees expect results.
Looks like originally published in early 2016, judging from google search results. No worries!
I think the article on Dr.Huestis is an old one - it says " In April 2016, she will be awarded the Saferstein Memorial Distinguished Lecturer at Northeastern University. " I think she retired to come work at cannabix.
A stoner buddy of mine said that his stoner brother in California told him they are giving DUI's out there after using a pot breathalyzer. Somethign is afoot.
I'm OK with that, I have a good sized chunk of shares that flops from short term to long term at the end of January. I'd rather not give Uncle Sugar any more than neccessary.
The end opposite of the blow tube is as clear a photoshop as anything. The logo was obviously put there to cover some detail that is key - or proprietary. My guess is that is the side that the exhaust is on.
I'll just address what I perceive as the advantages that Cannabix has over Hound Labs. Cannabix has been (relatively) forthcoming over how their device works. Hound Labs has given some hints and then said nothing. Cannabix measures the THC level in breath, directly. Hound Labs uses a tag molecule that attaches to the THC and then measures the concentration of the tag molecule. I have read that Hound Labs measures THC in saliva and I have read that they measure THC in breath. I don't know which one is correct. Cannabix measures in breath. If a device measures in saliva it may be disqualified in jurisdictions that prohibit collection of DNA without a warrant. Hound Labs says they are in testing but give zero verifiable details of what the testing process entails, what agencies or jurisdictions they are working with, etc. Biggest advantage Cannabix has is they are a publicly traded company and issue news every now and then. Hound Labs is privately held, they are less forthcoming with news.
He already replied with a "thanks!". In looking at his website he does a lot of writing on the benefits of cannabis. He'd be a good ally in the media.
I just Emailed Mr. Downs & suggested he check out the Cannabix Technologies breathalyzer - let's see where he goes.
Drawing blood is what this device ultimately will protect people from. In Florida, the statutes for driving while impaired are such that a warrant is required to draw blood. A refusal to submit to a breathalyzer test typically results in a phone call to a judge who issues the warrant. Game over. The alcohol breathalyzer stands up in court on its own without a blood draw. The Cannabix breathalyzer (in MY opinion) will start out as a tool to establish probable cause to request a warrant for a blood draw. I know if it was my device this is how I'd start out marketing it. I would also start it out with a "yes/no" readout, and sell it relatively cheap. Then once it became accepted by the courts I'd change it to a level readout (that's the one I'd be submitting for approval, BTW), and I'd offer the purchasers of the earlier models an upgrade to a level detector instead of a presence detector for a nominal fee.
They can sell anything if there is a buyer. My point was that the market is screaming for this, so there is a buyer. The burden will be on the buyers to develop protocols for using an as of yet uncertified device. If the judge who issues the warrants believes that an electronic instrument is more credible than talking to a dog, then the warrant gets issued, the blood gets drawn, and the person is either charged or released.
Remember that there is also a huge demand for this device. Even if the "certification" drags on, if (IF) they can complete a hand held device, the market may demand to use it as a tool to determine probable cause for detainment and obtaining a warrant to draw blood. Probable cause derived from an instrument that is in the final stages of development can't be too far of a stretch - they talk to dogs for it now.
On another note, it's important to look at their deveopment team. Dr. Yost has a track record of success, and doesn't go off half cocked sending his projects out into the world. There is no doubt in my mind (you need to make your own decisions) that this will work from a technical standpoint. Commercially there is a market. From a regulatory perspective, I really don't know, but it has to be better than asking animals if a person is OK to drive. Really, Dr. Doolittle... You're telling me I'm high, but you're the one asking questions of a dog..... (I have nothing against dogs - they make great pets & companions).
The decision to have separate licenses may not have been in the hands of Cannabix and Breathtec. It may have been the University of Florida. The university has a history of great product innovations, and has been burned early on by lack of proper exploitation of their efforts. They get nothing for Gatorade - it was a tough lesson. They probably issue very narrowly worded licenses for use of their developments so that future uses can bring their full potential of revenues back to the school.
I think there is a clause that the warrant shares have to be held for several months, to prevent that from happening. I agree on the analysis if there is no such clause, but I'm pretty sure it's in there.
So in the beginning of September it was around .15 +- and now it's around .30+-. Not sure what your point is. Things fluctuate day to day, hour to hour. That's how day traders make money & lose money. To the folks who keep bashing this stock based on their own greed (desire to drive price down so they can buy more) their distrust of folks of other races/nationalities, etc, ask yourself this. Why would University of Florida and Doctor Yost align themselves with a company that was planning to do anything but succeed? UF has a lot of ventures like this - you may have heard of Gatorade to name one. They were a marketing success with Gatorade, but failed when it came to their commercial agreements. With a solid commercial agreement on the Cannabix Breathalyzer everyone comes out net positive. This isn't two or three guys in a garage in the pacific northwest scamming on how to come up with a couple bucks to buy their next dime bag. This is the real deal. Good technology, a solid development team, and a solid group of advisors to properly exploit the technology.
Cannabix has spit separation in front of the analyzer. FOAD.
Um, the last article out said it is based on saliva. A cotton swab with the tag molecules collects the saliva, the machine reads it. Takes about three minutes. No bueno. Primative.
Competition is primative and based on saliva. Cannabix device is the standard that they will be compared to.
Mairjuana in Florida coming - no, it's here. I live in FL and it's everywhere. Whether it's legal or not, the cat is out of the bag and this device is needed. That's what I've been saying all along - if you are pro legalization, you want this device to be on line, because you're OK to drive in a few hours. If you are against legalization, you want this device to be on line to prosecute anyone using marijuana that operates a motor vehicle. As hush-hush as the press releases from Cannabix have been, the competitors have been even more secretive. One is public, the other private. If Cannabix is first to market they get a majority share, and if the technology is as good as it purports to be they will be able to hold onto it. I'm in long, may accumulate more while they are still very cheap.
"With up to nine states in the US voting on marijuana legalization measures this fall, the need for a marijuana breathalyzer is becoming ever critical"
You missed the first half of the last paragraph. MY interpretation of the tea leaves is that they will have Beta 2.0 in testing this fall, when up to nine additional states vote on legalization. Of course everyone needs to do their own research and interpret things as they see fit. I've been holding this for a year and a half, another couple months isn't going to hurt - it lets more of my holdings roll to long term investments, I'm OK wiht that.
They gave indications on timing for beta 2.0 and field testing in the press release.
The Company expects to complete a “Beta 2.0” device that will be prepared for external testing.
Kal Malhi, President, commented, “Cannabix is moving quickly towards launching our FAIMS based Cannabix Marijuana Breathalyzer and completing external testing. With up to nine states in the US voting on marijuana legalization measures this fall, the need for a marijuana breathalyzer is becoming ever critical and we believe our timing for external testing of the Cannabix Marijuana Breathalyzer will coincide with further states legalizing marijuana.”
The way I read these two excerpts from the press release, they expect to have the Beta 2.0, and expect to have it in external testing by election day. States legalize by putting it on the ballot and voting for it. Most of my shares are long term holdings, if it takes another few months to hit I'm OK with that. Good luck.
The other difference between Cannabix and Breathtec is that Cannabix is looking for a single molecule (THC). In speaking with a chemist friend of mine (PhD chemist from Oxford, teaches at University of Florida), the biological markers for disease can vary in what molecule is found, from person to person. While Cannabix is trying to detect a certain molecule and correlate what it finds to blood concentration, Breathtech is looking for variations, so a library of targets needs to be assembled over time to ensure the non-invasive screening tests are meaningful. Their task is much more difficult.
I've found this board is much more useful if I screen out (ignore) the noise as well. If a person doesn't like the stock, sell it. Buy something else that you feel will perform better. I'm holding onto this one till it launches.
Demand is huge. Time line is not important on a micro scale, as long as they build the units for field testing, verify they work as anticipated, and keep moving on putting these in every police car in North America and the rest of the world. Demand will drive the stock price back up. Demand for the product, demand for the stock. They don't have to manufacture - they can license the design to a 3rd party.
As far as that article is concerned, it makes good points but in the end they won't matter. In society today, subjective observation won't hold up in court. Opinions won't hold up. What does get convictions are process driven convictions, which means an objective pass/fail criteria. It needs to be a number, regardless of the perceived impairment or lack thereof. The problem TODAY is there is no way to arrive at a number by the side of the road, which is why the decision is binary, if THC is in a driver's system, they are considered impaired. The Cannabix breathalyzer changes that, because it allows measurement to a degree of accuracy that a standard can be set by. It may take a couple of years to determine exactly what the pass/fail levels are, but this is the device that will change the face of roadside impairment stops.
I agree with that as an end goal, but there is an intermediate step which puts units on the street, protects individuals against overly invasive searches, and provides law enforcement with a tool to determine probable cause to proceed with an arrest and further evidence gathering. This intermediate step will, in time, become the end step in securing evidence to prosecute, as it becomes understood and accepted. Anything that quantifies and gives a print-out is better than trying to interpret subjective data, on the street, to determine probable cause in a way that will hold up in court. Baby steps for Cannabix, huge leaps for stock price growth.
All that the field testing needs to establish is that there is probable cause to haul the suspect in for a blood test, or that there is no probable cause and release the suspect. A blood test holds up in court as forensic evidence, but it's overly invasive to blood test every motorist with a goofy personality. Enter the Cannabix Breathalyzer. It is a non-invasive screening tool at worst, a record of drugged driving that holds up in court at best. Either way this device is huge. Let's launch this thing and make some money!
The focus on putting the Cannabix breathalyzer out there should be on providing law enforcement with "probable cause". Once the officer on the scene has probable cause they can justify further invasive testing measures like drawing blood that would stand up in court. The beauty of the breathalyzer is it's fast, it's cheap to use(no consumables), and it would provide probable cause to go further or justification for ending a traffic stop and allowing a citizen to go on their way even while it's in the testing phase. No validation needed, just a sensor to check if we need to do a bit more. Provide it with a red light and a green light and put them on the street with factory set limit that reflects the state of an average person a little more than 2 hours after ingesting THC. This would take the burden of proof for the initial stop and make it less subjective. And Cannabix could sell thousands of units in this configuration, tomorrow. Then more later after it's validated.
And we are #10 on the breakout board
So to estimate the potential US market, there are approximately 1 million police officers in the US. If we estimate that there are four officers to each car (SWAG) we end up with a quarter million police cars. If 20% of the fleet is fitted with new breathalyzers in the first year via whatever funding comes up, that is 50,000 units, figure a sell price of $1500 per unit, that's $75,000,000 in potential sales. Adjust figures up or down to suit your own assessment, but for order of magnitude of what this is worth, there you go. Even if it's a quarter of that, $18M isn't a bad first year. Let's see that Beta!
#43 on the breakout boards.
The heavy users have the metabolized byproducts in their fat and blood for weeks after use has ceased, and the current urine tests do not discrimnate between the active THC molecule and the metabolized components. The use of mass spectroscopy changes that - it allows the detection to be very selective and very accurate. The technology using the "tag molecule" is suspect, because the tag will have to ONLY combine with the active THC molecule or the reading is erroneous. It's been 30 years since I took analytical chemistry - I remember that the "chemical" methods were crude. As Dr. Yost has said, mass spectroscopy is the gold standard. Now we just need him to turn this stock into gold.
The Pittcon is more of a convention for analytical chemists, as opposed to a stoner trade show. I do not expect much press to come from the 20 minute presentation. These are scientists showing off their newest brainstorms, not marketing guys hawking the shiniest new widget. I think Beta will be the make or break - they just need to get it out there on the street, literally.
The acrimony in recent posts is amazing. This company has been very thin on releasing information for whatever reasons they see fit. In the absence of words, we need to figure them out based on their actions (verifiable). They secured an agreement with UF to get access to technical leaders in the field and to get access to the technology being developed by those experts. They had a year to decide if the technology was the right fit, and they moved on it in half that time. The state of Alpha is almost irrelevant, as MY UNDERSTANDING IS that it was based on a different technology from what UF brought to the table. MY INTERPRETATION of the indicators above, and the presentation scheduled for March, and the recent PP is that they are close. I’m watching two intelligent people rip each other’s throats out arguing about splitting hairs. MY BET is by mid-March we’ll all be arguing over which yacht is better. Relax. Let the chips fall where they will, at this point I’ve been in almost a year, my average is about .28, I’m holding and waiting, and I don’t think there is long to wait.
Agreed. The UF partnership brings a level of credibility to this venture that two guys working out of their garage will never have, no matter how smart or how good their product. Note that last summer the press release said they were "well funded", not "fully funded". Well funded, in my interpretation, means they have operating capital on hand to continue moving forward. The time period was not defined. Now they are raising additional capital, fresh on the heels of their announcement that they are buying patent rights, to move to the next step.
There is speculation that the dilution of shares will be to insiders only, and it has been expressed that the amount is a finite amount. Only selling the shares to insiders has the added benefit of not dumping them on the open market, and not exposing the open market to the risk associated with holding those shares or the immediate dilution of available shares en masse.
This all points in a positive direction. I went off half cocked yesterday without reading all the way thru what was going on - I've also been fairly patient, and will continue to be as long as there is some life to this thing.
OK, in light of the news vacuum over the past 6 to 8 months, let's resume the stockholder speculation game. There is a lot of discussion about Breathtec, UF, DR. Yost, and our dear abandoned child, BLOZF. UF is involved in all. Funding has pretty strict limits on what it can be spent on - Cannabix money can't be used for medical research, medical research money can't be used for pot breathalyzer research, etc. Perhaps, just perhaps, they are well on their way to developing both units. Perhaps they are also well on their way to getting the pot unit to also detect cocaine, heroin, barbituates, etc. What I see is they pump the breathtec stock, then issue it at the same time they "finally" release beta, which also has other very marketable bells & whistles. Once everyone is smiling, they merge the two, formally and finally, as a company that makes breath analyzers that can do it all. Same housing, different programming and labels, huge value to everyone. Shared manufacturing, a good deal of shared marketing. And in my dreams they give a 1:1 stock swap for the new and it settles out at about $50/share. Eh? What thinks y'all?